| Product ID | 72123-007_ac4f048d-a497-4ece-e053-2995a90a9c93 |
| NDC | 72123-007 |
| Product Type | Human Otc Drug |
| Proprietary Name | Brillia Health Cough Control |
| Generic Name | Lapine Bradykinin Immune Globulin (12c, 30c, 50c), Lapine Morphine Immune Globulin (12c, 30c, 50c), Lapine Histamine Immune Globulin (12c, 30c, 50c) |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-31 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Hadaf LLC |
| Substance Name | LAPINE MORPHINE IMMUNE GLOBULIN; LAPINE BRADYKININ IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN |
| Active Ingredient Strength | 12 [hp_C]/1; [hp_C]/1; [hp_C]/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |